Eco-evolution of cancer resistance

For the past 60 years, the goal of conventional cancer therapies has been the eradication of every cancer cell. To this end, patients are subjected to the highest possible doses of radiation and chemotherapy as well as radical surgeries. In the rare case in which eradication was possible, clinicians...

Full description

Saved in:
Bibliographic Details
Published in:Science translational medicine 2016-02, Vol.8 (327), p.327fs5-327fs5
Main Author: Klement, Giannoula L
Format: Article
Language:English
Subjects:
Drug Resistance, Neoplasm
Humans
Tumor Microenvironment
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c307t-b1cf6598040ebadb7b8a10f9d1dc5ac4066b287b4ea3415aca74dc1f7e0cd6c23
cites cdi_FETCH-LOGICAL-c307t-b1cf6598040ebadb7b8a10f9d1dc5ac4066b287b4ea3415aca74dc1f7e0cd6c23
container_end_page 327fs5
container_issue 327
container_start_page 327fs5
container_title Science translational medicine
container_volume 8
creator Klement, Giannoula L
description For the past 60 years, the goal of conventional cancer therapies has been the eradication of every cancer cell. To this end, patients are subjected to the highest possible doses of radiation and chemotherapy as well as radical surgeries. In the rare case in which eradication was possible, clinicians achieved long-term control of the disease. For the most part, however, upfront eradication is not possible, and despite intensive and very toxic therapies, the patient dies of the disease or of complications of therapy. As our understanding about the role of tumor microenvironment in tumor progression and drug resistance improves, we are realizing that the paradigm of killing all cancer cells may be flawed.
doi_str_mv 10.1126/scitranslmed.aaf3802
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1768559487</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1768559487</sourcerecordid><originalsourceid>FETCH-LOGICAL-c307t-b1cf6598040ebadb7b8a10f9d1dc5ac4066b287b4ea3415aca74dc1f7e0cd6c23</originalsourceid><addsrcrecordid>eNpNkEFLAzEUhIMotlb_gUjx5GVrXpJNskcprQoFL3oOydsEVrabmuwK_nu3tBVPbxhm5sFHyC3QBQCTjxmbPtkut1tfL6wNXFN2RqZQCVlIJtj5n-ZiQq5y_qRUal7KSzJhsgJWUZiS-xXGwn_Hduib2M1jmKPt0Kd58rnJ_V5fk4tg2-xvjndGPtar9-VLsXl7fl0-bQrkVPWFAwyyrDQV1DtbO-W0BRqqGmosLQoqpWNaOeEtFzA6VokaIShPsZbI-Iw8HHZ3KX4NPvdm22T0bWs7H4dsQEldlpXQaoyKQxRTzDn5YHap2dr0Y4CaPR3zn4450hlrd8cPg9v7p9IJB_8FPsBk8Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1768559487</pqid></control><display><type>article</type><title>Eco-evolution of cancer resistance</title><source>Alma/SFX Local Collection</source><creator>Klement, Giannoula L</creator><creatorcontrib>Klement, Giannoula L</creatorcontrib><description>For the past 60 years, the goal of conventional cancer therapies has been the eradication of every cancer cell. To this end, patients are subjected to the highest possible doses of radiation and chemotherapy as well as radical surgeries. In the rare case in which eradication was possible, clinicians achieved long-term control of the disease. For the most part, however, upfront eradication is not possible, and despite intensive and very toxic therapies, the patient dies of the disease or of complications of therapy. As our understanding about the role of tumor microenvironment in tumor progression and drug resistance improves, we are realizing that the paradigm of killing all cancer cells may be flawed.</description><identifier>ISSN: 1946-6234</identifier><identifier>EISSN: 1946-6242</identifier><identifier>DOI: 10.1126/scitranslmed.aaf3802</identifier><identifier>PMID: 26912901</identifier><language>eng</language><publisher>United States</publisher><subject>Drug Resistance, Neoplasm ; Humans ; Tumor Microenvironment</subject><ispartof>Science translational medicine, 2016-02, Vol.8 (327), p.327fs5-327fs5</ispartof><rights>Copyright © 2016, American Association for the Advancement of Science.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c307t-b1cf6598040ebadb7b8a10f9d1dc5ac4066b287b4ea3415aca74dc1f7e0cd6c23</citedby><cites>FETCH-LOGICAL-c307t-b1cf6598040ebadb7b8a10f9d1dc5ac4066b287b4ea3415aca74dc1f7e0cd6c23</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26912901$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Klement, Giannoula L</creatorcontrib><title>Eco-evolution of cancer resistance</title><title>Science translational medicine</title><addtitle>Sci Transl Med</addtitle><description>For the past 60 years, the goal of conventional cancer therapies has been the eradication of every cancer cell. To this end, patients are subjected to the highest possible doses of radiation and chemotherapy as well as radical surgeries. In the rare case in which eradication was possible, clinicians achieved long-term control of the disease. For the most part, however, upfront eradication is not possible, and despite intensive and very toxic therapies, the patient dies of the disease or of complications of therapy. As our understanding about the role of tumor microenvironment in tumor progression and drug resistance improves, we are realizing that the paradigm of killing all cancer cells may be flawed.</description><subject>Drug Resistance, Neoplasm</subject><subject>Humans</subject><subject>Tumor Microenvironment</subject><issn>1946-6234</issn><issn>1946-6242</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNpNkEFLAzEUhIMotlb_gUjx5GVrXpJNskcprQoFL3oOydsEVrabmuwK_nu3tBVPbxhm5sFHyC3QBQCTjxmbPtkut1tfL6wNXFN2RqZQCVlIJtj5n-ZiQq5y_qRUal7KSzJhsgJWUZiS-xXGwn_Hduib2M1jmKPt0Kd58rnJ_V5fk4tg2-xvjndGPtar9-VLsXl7fl0-bQrkVPWFAwyyrDQV1DtbO-W0BRqqGmosLQoqpWNaOeEtFzA6VokaIShPsZbI-Iw8HHZ3KX4NPvdm22T0bWs7H4dsQEldlpXQaoyKQxRTzDn5YHap2dr0Y4CaPR3zn4450hlrd8cPg9v7p9IJB_8FPsBk8Q</recordid><startdate>20160224</startdate><enddate>20160224</enddate><creator>Klement, Giannoula L</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20160224</creationdate><title>Eco-evolution of cancer resistance</title><author>Klement, Giannoula L</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c307t-b1cf6598040ebadb7b8a10f9d1dc5ac4066b287b4ea3415aca74dc1f7e0cd6c23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Drug Resistance, Neoplasm</topic><topic>Humans</topic><topic>Tumor Microenvironment</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Klement, Giannoula L</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Science translational medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Klement, Giannoula L</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Eco-evolution of cancer resistance</atitle><jtitle>Science translational medicine</jtitle><addtitle>Sci Transl Med</addtitle><date>2016-02-24</date><risdate>2016</risdate><volume>8</volume><issue>327</issue><spage>327fs5</spage><epage>327fs5</epage><pages>327fs5-327fs5</pages><issn>1946-6234</issn><eissn>1946-6242</eissn><abstract>For the past 60 years, the goal of conventional cancer therapies has been the eradication of every cancer cell. To this end, patients are subjected to the highest possible doses of radiation and chemotherapy as well as radical surgeries. In the rare case in which eradication was possible, clinicians achieved long-term control of the disease. For the most part, however, upfront eradication is not possible, and despite intensive and very toxic therapies, the patient dies of the disease or of complications of therapy. As our understanding about the role of tumor microenvironment in tumor progression and drug resistance improves, we are realizing that the paradigm of killing all cancer cells may be flawed.</abstract><cop>United States</cop><pmid>26912901</pmid><doi>10.1126/scitranslmed.aaf3802</doi></addata></record>
fulltext fulltext
identifier ISSN: 1946-6234
ispartof Science translational medicine, 2016-02, Vol.8 (327), p.327fs5-327fs5
issn 1946-6234
1946-6242
language eng
recordid cdi_proquest_miscellaneous_1768559487
source Alma/SFX Local Collection
subjects Drug Resistance, Neoplasm
Humans
Tumor Microenvironment
title Eco-evolution of cancer resistance
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T15%3A41%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Eco-evolution%20of%20cancer%20resistance&rft.jtitle=Science%20translational%20medicine&rft.au=Klement,%20Giannoula%20L&rft.date=2016-02-24&rft.volume=8&rft.issue=327&rft.spage=327fs5&rft.epage=327fs5&rft.pages=327fs5-327fs5&rft.issn=1946-6234&rft.eissn=1946-6242&rft_id=info:doi/10.1126/scitranslmed.aaf3802&rft_dat=%3Cproquest_cross%3E1768559487%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c307t-b1cf6598040ebadb7b8a10f9d1dc5ac4066b287b4ea3415aca74dc1f7e0cd6c23%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1768559487&rft_id=info:pmid/26912901&rfr_iscdi=true